Current position:Home >Product >
tris[4-[N-α-(N-t-butoxycarbonyl-L-phenylalanyl)-N-ε-t-butoxycarbonyl-L-lysyl]aminophenyl]methane
tris[4-[N-α-(N-t-butoxycarbonyl-L-phenylalanyl)-N-ε-t-butoxycarbonyl-L-lysyl]aminophenyl]methane(378801-78-6)
- Name: tris[4-[N-α-(N-t-butoxycarbonyl-L-phenylalanyl)-N-ε-t-butoxycarbonyl-L-lysyl]aminophenyl]methane
- Synonyms:
- Molecular Formula:
- Molecular Weight:1716.14
- CAS Registry Number:378801-78-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1260598-15-9/3-hydroxy-1-(6-methyl-pyridazin-3-yl)-5-(4-trifluoromethoxy-phenyl)-4-(6-trifluoromethyl-pyridine-3-carbonyl)-1,5-dihydro-pyrrol-2-one
- 1266083-91-3/4-methoxy-N-[1-(4-methoxyphenyl)-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl]benzamide
- 1267854-30-7/5-(4-amino-3-chlorophenyl)pyridin-2-amine
- 1194981-65-1/5-methyl-2-methylsulfanyl-3-(3-chlorophenylsulfonyl)-6,7,8,9-tetrahydropyrazolo[1,5-a]pyrido[4,3-e]pyrimidine
- 1194981-88-8/C17H18N4O2S*ClH
- 945395-71-1/4-[[4-[(5-chlorobenzo[1,3]dioxol-4-yl)-(2-methoxyethyl)amino]pyrimidin-2-yl]amino]benzenesulfonamide
- 1021163-30-3/2-(2,6-dichlorophenyl)-3H-benzoimidazole-5-carboxylic acid (4-butylphenyl)-amide
- 883159-07-7/C24H26ClN5O2
- 880103-61-7/trans-(2R,4S)-4-{4-[(3,5-bis-trifluoromethyl-benzyl)-(2-methyl-2H-tetrazol-5-yl)-amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carbonyl}-cyclohexanecarboxylic acid methyl ester
- 886435-04-7/C8H4Cl(123)I
- 887272-38-0/3-Phenyl-3-[5-({[2-(phenylsulfanyl)-3-pyridinyl]carbonyl}amino)-1H-benzimidazol-1-yl]propanoic acid
- 745041-93-4/2-[3-(4-hexadecanyloxyphenyl)propanoylamino]-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,9-O-isopropylidene-D-ribo-1,3,4-nonanetriol
- 885616-58-0/1-(4-chloro-phenyl)-2-(2,4-dichloro-phenyl)-8-methoxy-9-phenyl-1,9-dihydro-purin-6-one
- 888321-40-2/tert-butyl [(3R,4R)-6-oxo-4-(2,5-difluorophenyl)piperidin-3-yl]carbamate
- 847492-47-1/tert-butyl ((3R)-1-{4-(2-chloro-5-fluorobenzyl)-3-(dimethoxymethyl)-1-[(dimethylamino)sulfonyl]-1H-pyrazol-5-yl}piperidin-3-yl)carbamate
- 240802-10-2/C70H108N18O29
- 906002-52-6/(1-aza-bicyclo[2.2.2]oct-4-ylmethyl)-(4-fluoro-benzyl)-[2-fluoro-5-(1H-indol-5-yl)-benzyl]-amine acetate
- 905925-03-3/C2HF3O2*C22H29N5O2S
- 360795-37-5/6-{4-[N'-(4-Methoxy-benzylidene)-hydrazino]-phenyl}-5-methyl-4,5-dihydro-2H-pyridazin-3-one
- 378801-78-6/tris[4-[N-α-(N-t-butoxycarbonyl-L-phenylalanyl)-N-ε-t-butoxycarbonyl-L-lysyl]aminophenyl]methane
- 398498-06-1/N-{5-methansulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}-4-fluorobenzamide
- 330840-75-0/3-(2-(R)-cyclopropylmethyl-3-(S)-hydroxyl-1-oxoheptyl)amino-1-benzyl-5-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
- 330840-37-4/3-(3-(tert-butoxycarbonylpyrrolidin-2-(R)-yl)-3-(R)-hydroxyl-2-(R)-methyl-1-oxopropyl)amino-7-chloro-5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
- 528599-91-9/(5Z,7E)-(1S,3R,24R)-25-(5-butyloxazole-2-yl)-24-[[(2,2-dimethyl-3-hydroxy)-1-oxopropyl]oxy]-26,27-cyclo-9,10-secocholesta-5,7,10(19)-triene-1,3-diol
- 353280-75-8/(-)-2-(Benzo[2,1,3]oxadiazol-5-yloxy)-N-{1-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-ethyl}-nicotinamide
- 591779-97-4/(3R)-1'-[2,6-Bis-(4-chloro-phenyl)-pyridine-4-carbonyl]-[1,4']bipiperidinyl-3-carboxylic acid methyl-(1-methyl-piperidin-4-yl)-amide
- 488126-56-3/(4aS,9bR)-8-(2,4-dichlorophenyl)-6-methoxy-1,2,3,4,4a,9b,-hexahydro[1]benzofuro[3,2-c]pyridine
- 485820-05-1/3-(4-Methoxyphenyl)-5-methoxycarbonylamino-2H-indeno-[1,2-c]pyrazol-4-one
- 442560-98-7/4-(2,6-Difluoro-phenyl)-3-[1-[3,5-dimethyl-4-(4-methyl-piperazine-1-carbonyl)-1H-pyrrol-2-yl]-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one
- 389630-39-1/1-(4-Benzoyl-2-(R)-methyl-piperazin-1-yl)-2-[7-(5-cyclopentylamino-[1,2,4]oxadiazol-3-yl)-4-fluoro-1H-indol-3-yl]-ethane-1,2-dione